<bill session="118" type="h" number="2880" updated="2025-05-27T14:14:48Z">
  <state datetime="2023-12-06">REPORTED</state>
  <status>
    <unknown datetime="2023-12-06"/>
  </status>
  <introduced datetime="2023-04-26"/>
  <titles>
    <title type="display">Protecting Patients Against PBM Abuses Act</title>
    <title type="short" as="introduced">Protecting Patients Against PBM Abuses Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to establish certain requirements for pharmacy benefit managers under part D of the Medicare program.</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="A000372" joined="2023-11-28"/>
    <cosponsor bioguide_id="A000148" joined="2023-04-26"/>
    <cosponsor bioguide_id="B001300" joined="2024-05-07"/>
    <cosponsor bioguide_id="B001303" joined="2023-04-26"/>
    <cosponsor bioguide_id="C001134" joined="2024-07-22"/>
    <cosponsor bioguide_id="C001054" joined="2023-09-13"/>
    <cosponsor bioguide_id="C001090" joined="2024-05-22"/>
    <cosponsor bioguide_id="C001127" joined="2024-05-07"/>
    <cosponsor bioguide_id="C001061" joined="2024-04-15"/>
    <cosponsor bioguide_id="D000230" joined="2024-05-16"/>
    <cosponsor bioguide_id="D000628" joined="2023-08-25"/>
    <cosponsor bioguide_id="F000465" joined="2023-10-30"/>
    <cosponsor bioguide_id="F000459" joined="2024-05-21"/>
    <cosponsor bioguide_id="F000474" joined="2024-07-23"/>
    <cosponsor bioguide_id="G000061" joined="2024-10-04"/>
    <cosponsor bioguide_id="G000576" joined="2024-06-26"/>
    <cosponsor bioguide_id="H001086" joined="2023-11-08"/>
    <cosponsor bioguide_id="H001067" joined="2024-05-21"/>
    <cosponsor bioguide_id="J000309" joined="2024-05-22"/>
    <cosponsor bioguide_id="J000307" joined="2024-08-13"/>
    <cosponsor bioguide_id="K000399" joined="2024-08-02"/>
    <cosponsor bioguide_id="K000391" joined="2024-09-09"/>
    <cosponsor bioguide_id="L000598" joined="2024-07-30"/>
    <cosponsor bioguide_id="L000599" joined="2024-06-25"/>
    <cosponsor bioguide_id="L000593" joined="2024-07-23"/>
    <cosponsor bioguide_id="M000317" joined="2023-04-26"/>
    <cosponsor bioguide_id="M000871" joined="2023-09-22"/>
    <cosponsor bioguide_id="M001218" joined="2024-06-18"/>
    <cosponsor bioguide_id="M001226" joined="2024-11-18"/>
    <cosponsor bioguide_id="M001205" joined="2024-01-10"/>
    <cosponsor bioguide_id="M001215" joined="2023-07-26"/>
    <cosponsor bioguide_id="M001206" joined="2024-10-11"/>
    <cosponsor bioguide_id="N000194" joined="2024-11-01"/>
    <cosponsor bioguide_id="R000612" joined="2024-07-22"/>
    <cosponsor bioguide_id="R000305" joined="2023-08-25"/>
    <cosponsor bioguide_id="S001226" joined="2024-06-12"/>
    <cosponsor bioguide_id="S001189" joined="2024-05-07"/>
    <cosponsor bioguide_id="S001207" joined="2024-04-23"/>
    <cosponsor bioguide_id="S001199" joined="2024-09-19"/>
    <cosponsor bioguide_id="S001209" joined="2024-06-11"/>
    <cosponsor bioguide_id="T000478" joined="2024-10-11"/>
    <cosponsor bioguide_id="V000129" joined="2024-03-19"/>
    <cosponsor bioguide_id="V000133" joined="2023-06-30"/>
    <cosponsor bioguide_id="V000135" joined="2024-09-09"/>
    <cosponsor bioguide_id="V000136" joined="2024-06-03"/>
  </cosponsors>
  <actions>
    <action datetime="2023-04-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-04-26" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-04-26">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-04-28">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2023-11-15">
      <text>Subcommittee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-11-15">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote.</text>
    </action>
    <action datetime="2023-12-05">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.</text>
    </action>
    <action datetime="2024-12-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Markup By, Markup By, Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2024-01-02T20:23:07Z" status="Introduced in House">Protecting Patients Against PBM Abuses Act

This bill establishes requirements for Medicare pharmacy benefit managers (PBMs) with respect to remuneration, payments, and fees.

Specifically, the bill restricts PBMs that are under contract with plans under the Medicare prescription drug benefit or Medicare Advantage from (1) receiving income for their services other than flat dollar amount service fees; (2) basing any service fees on the prices of covered drugs or any associated discounts, rebates, or other remuneration; (3) charging plan sponsors for ingredient costs or dispensing fees in amounts that are different than what is reimbursed to the pharmacy; or (4) reimbursing network pharmacies for less than that what is reimbursed to PBM-affiliated pharmacies.

Such PBMs must also report on the difference between certain costs for drugs on the plan's formulary and those that are not on the formulary but are therapeutically equivalent. PBMs must also report certain information regarding rebates and fees they receive from drug manufacturers; the Centers for Medicare &amp; Medicaid Services must publish this and other information that is currently reported by PBMs online.</summary>
</bill>
